Nuclear Targeting and Cell Cycle Regulatory Function of Human BARD1
Open Access
- 1 March 2005
- journal article
- Published by Elsevier
- Vol. 280 (10) , 8855-8861
- https://doi.org/10.1074/jbc.m413741200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancerJournal of Medical Genetics, 2004
- Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal InstabilityMolecular and Cellular Biology, 2003
- Germline mutations of the BRCA1‐associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterationsGenes, Chromosomes and Cancer, 2002
- The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activityCurrent Opinion in Genetics & Development, 2002
- Identification of BARD1 as Mediator between Proapoptotic Stress and p53-Dependent ApoptosisMolecular Cell, 2001
- Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis developmentProceedings of the National Academy of Sciences, 2001
- The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived MutationJournal of Biological Chemistry, 2001
- In Vitro Repression of Brca1-associated RING Domain Gene, Bard1, Induces Phenotypic Changes in Mammary Epithelial CellsThe Journal of cell biology, 1998
- Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancersHuman Molecular Genetics, 1998
- The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the MouseCell, 1996